Login

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Restricted cash and cash equivalents
Accounts receivable, net
Inventories, net
Prepaid expenses and other current assets
Income taxes receivable
Assets held for sale (NOTE 3)
Total current assets
PROPERTY, PLANT AND EQUIPMENT, NET
OPERATING LEASE ASSETS
GOODWILL
OTHER INTANGIBLES, NET
DEFERRED INCOME TAXES
OTHER ASSETS
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS’ DEFICIT
CURRENT LIABILITIES:
Accounts payable and accrued expenses
Current portion of legal settlement accrual
Current portion of operating lease liabilities
Current portion of long-term debt
Liabilities held for sale
Income taxes payable
Total current liabilities
DEFERRED INCOME TAXES
LONG-TERM DEBT, LESS CURRENT PORTION, NET
LONG-TERM LEGAL SETTLEMENT ACCRUAL, LESS CURRENT PORTION
OPERATING LEASE LIABILITIES, LESS CURRENT PORTION
OTHER LIABILITIES
LIABILITIES SUBJECT TO COMPROMISE
SHAREHOLDERS’ DEFICIT:
Euro deferred shares, $0.01 par value; 4,000,000 shares authorized and issued at both December 31, 2023 and December 31, 2022
Ordinary shares, $0.0001 par value; 1,000,000,000 shares authorized; 235,219,612 and 235,208,039 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total shareholders’ deficit
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT
Euro deferred shares, par value (in dollars per share)
Euro deferred shares, shares authorized (in shares)
Common stock, par value (in dollars per share)
Common stock, shares authorized (in shares)
Common stock, shares issued (in shares)
Common stock, shares outstanding (in shares)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support